Loading…
Genelux Corporation is projected to rise to $3.79 by 2027, a +24% move from its current price of $3.06. GNLX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $2.96 | $3.06 | $3.16 | +0.01% |
| May 30 | $2.92 | $3.06 | $3.20 | +0.03% |
| May 31 | $2.89 | $3.06 | $3.24 | +0.04% |
| Jun 1 | $2.87 | $3.06 | $3.27 | +0.06% |
| Jun 2 | $2.85 | $3.06 | $3.29 | +0.07% |
| Jun 3 | $2.83 | $3.06 | $3.32 | +0.08% |
| Jun 4 | $2.81 | $3.06 | $3.34 | +0.10% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.81 | $3.06 | $3.34 | +0.10% |
| Week 2 | $2.72 | $3.07 | $3.46 | +0.19% |
| Week 3 | $2.65 | $3.07 | $3.56 | +0.29% |
| Week 4 | $2.59 | $3.07 | $3.65 | +0.39% |
| Week 5 | $2.54 | $3.07 | $3.72 | +0.48% |
| Week 6 | $2.50 | $3.08 | $3.80 | +0.58% |
| Week 7 | $2.46 | $3.08 | $3.86 | +0.68% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Genelux Corporation is a clinical-stage biopharmaceutical company focused on developing oncolytic viral immunotherapies for patients with aggressive and/or difficult-to-treat solid tumors.
Its lead product candidate is Olvi-Vec (olvimulogene nanivacirepvec), a proprietary modified strain of the vaccinia virus indicated for the treatment of ovarian cancer. The company also offers CHOICE, a technology and discovery and development platform, and has developed an extensive library of isolated and engineered oncolytic VACV immunotherapeutic product candidates.
Genelux was incorporated in 2001 and is headquartered in Westlake Village, California.
Genelux Corporation trades at $2.92, with a market cap of $130.93M and a rank of 4099. These figures place Genelux among smaller-cap healthcare names with a clinical-stage focus.
The current price is $2.92 and the market capitalization is $130.93M, reflected in a rank of 4099. The price outlook, based on the provided year-by-year forecast, shows an upside trajectory over the longer term, with the average price rising from $2.92 in 2026 to $24.70 by 2050 and the maximum forecast reaching as high as $49.70 in 2050.
In 2026 the forecast is neutral with an average price of $2.92 and no ROI indicated; from 2027 onward the outlook turns bullish, with yearly average prices and progressively higher ROIs culminating in a 2050 average of $24.70 and a 746 ROIs. These numbers reflect a long-run upside potential but are not guarantees.
A major floor 27.2% below — a decisive break under it would weaken the trend.
The nearest floor, 18.3% below — buyers have tended to step in here.
The nearest ceiling, 4.2% above — a clean break opens room to run.
A major ceiling 17.9% above — clearing it would confirm fresh momentum.
Key GNLX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of GNLX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.97 | Buy | $2.98 | Buy |
| MA 10 | $2.96 | Buy | $2.95 | Buy |
| MA 20 | $2.89 | Buy | $2.89 | Buy |
| MA 50 | $2.70 | Buy | $2.82 | Buy |
| MA 100 | $2.74 | Buy | $3.01 | Buy |
| MA 200 | $3.77 | Sell | $3.33 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 59.12 | Neutral |
| Stoch RSI (14) | 51.40 | Neutral |
| CCI (20) | 96.89 | Neutral |
| Williams %R (14) | -33.33 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | -1.61 | Sell |
| Bollinger %B (20,2) | 0.77 | Neutral |
| Stochastic %K (14) | 66.67 | Neutral |
| TRIX (15) | 0.44 | Buy |
| Awesome (5,34) | 0.19 | Buy |
| Ultimate (7,14,28) | 62.68 | Neutral |
| Momentum (10) | 0.09 | Buy |
| Aroon Osc (25) | 40.00 | Buy |
| Hull MA (9) | 3.00 | Buy |
| ADX (14) | 12.92 | Neutral |
| ATR (14) | 0.09 | Info |
The 30-day technical picture is bullish. RSI (14) sits at 50, indicating balanced near-term momentum.
The near-term trend is supported by the 50-day simple moving average at $2.68 and the 200-day simple moving average at $3.77, giving a sense of a nearby resistance around longer-term moving-average levels.
Key levels to monitor are a support at $2.50 and resistance at $3.19. The 30-day price range runs from $2.34 to $3.65, while annualized volatility sits at 60%, underscoring meaningful price movement potential relative to the current base.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.30 | $3.06 | $4.40 | 0% | Neutral | |
| $2.95 | $3.79 | $5.19 | +24% | Bullish | |
| $2.97 | $3.94 | $5.62 | +29% | Bullish | |
| $3.28 | $4.48 | $6.59 | +46% | Bullish | |
| $3.46 | $4.84 | $7.33 | +58% | Bullish | |
| $4.29 | $6.13 | $9.50 | +100% | Bullish | |
| $5.26 | $7.68 | $12.17 | +151% | Bullish | |
| $5.53 | $8.24 | $13.31 | +169% | Bullish | |
| $5.98 | $9.08 | $14.93 | +197% | Bullish | |
| $6.17 | $9.54 | $15.95 | +212% | Bullish | |
| $9.65 | $16.25 | $29.10 | +431% | Bullish | |
| $15.43 | $30.15 | $59.67 | +885% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $2.30 | $3.06 | $3.62 | +0.00% |
| June 2026 | $2.67 | $3.15 | $3.82 | +3.05% |
| July 2026 | $2.60 | $3.10 | $3.81 | -1.73% |
| August 2026 | $2.63 | $3.15 | $3.92 | +1.73% |
| September 2026 | $2.71 | $3.28 | $4.12 | +3.96% |
| October 2026 | $2.69 | $3.27 | $4.15 | -0.11% |
| November 2026 | $2.67 | $3.26 | $4.17 | -0.27% |
| December 2026 | $2.78 | $3.42 | $4.40 | +4.74% |
Click any year to see its month-by-month GNLX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The GNLX price prediction for 2026 points to an average of $3.06 (low $2.30, high $4.40) — a potential gain of 0% on today's $3.06. Price action looks broadly range-bound.
In 2027, GNLX is projected to trade between $2.95 and $5.19, averaging $3.79 — a potential gain of +24% from today's $3.06. That is up +24% on the projected 2026 average. Buyers look set to stay in control over this stretch.
Genelux Corporation's 2028 outlook centres on $3.94, within a $2.97 to $5.62 range. That is up +4% on the projected 2027 average. That marks a +29% change versus current levels. Momentum favours further upside here.
By 2029, GNLX could reach as high as $6.59, with a base case around $4.48 and support toward $3.28 — roughly +46% from $3.06. Buyers look set to stay in control over this stretch.
Expect GNLX to range from $3.46 to $7.33 through 2030. The $4.84 average target implies a +58% move from current prices. That is up +8% on the projected 2029 average. Momentum favours further upside here.
The GNLX price prediction for 2031 points to an average of $6.13 (low $4.29, high $9.50) — a potential gain of +100% on today's $3.06. Buyers look set to stay in control over this stretch.
In 2032, GNLX is projected to trade between $5.26 and $12.17, averaging $7.68 — a potential gain of +151% from today's $3.06. That is up +25% on the projected 2031 average. Momentum favours further upside here.
Genelux Corporation's 2033 outlook centres on $8.24, within a $5.53 to $13.31 range. That is up +7% on the projected 2032 average. That marks a +169% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, GNLX could reach as high as $14.93, with a base case around $9.08 and support toward $5.98 — roughly +197% from $3.06. Momentum favours further upside here.
Expect GNLX to range from $6.17 to $15.95 through 2035. The $9.54 average target implies a +212% move from current prices. That is up +5% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The GNLX price prediction for 2040 points to an average of $16.25 (low $9.65, high $29.10) — a potential gain of +431% on today's $3.06. Momentum favours further upside here.
In 2050, GNLX is projected to trade between $15.43 and $59.67, averaging $30.15 — a potential gain of +885% from today's $3.06. That is up +86% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in GNLX today (≈ 326.797386 GNLX) could be worth
$9,854.53
+$8,854.53 (+885%) by 2050 · US Dollar
Based on the average projected GNLX price of $30.15 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in GNLXwould be worth at today's price.
$1,000 invested in GNLX on May 27, 2025 (≈ 393.700793 GNLX) would be worth
$1,204.72
+$204.72 (+20.5%) today · 1.20× · US Dollar
Based on a GNLX entry price of $2.54 vs. today's $3.06.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.93 | $1,044.37 | +4.4% |
| 1 month ago | $2.56 | $1,195.31 | +19.5% |
| 3 months ago | $2.89 | $1,058.82 | +5.9% |
| 6 months ago | $5.56 | $550.36 | -45.0% |
| 1 year ago | $2.54 | $1,204.72 | +20.5% |
| All time (3.3y) ago | $6.15 | $497.56 | -50.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our GNLX forecast.
Our base-case forecast reaches $6.10 around 2031.
Implied market cap at $6.10: $273.53M
The multi-year forecast points to a meaningful upside from the mid-2020s onward, with bullish sentiment across the horizon. In 2030 the average price is $4.28 and the max is $6.55, representing a 46.7 evaluation (ROI) in the year and a bullish stance.
In 2040 the average price is $13.59 with a max of $24.68 and a 365.4 ROI, continuing the bullish trajectory. By 2050 the forecast shows an average of $24.70, a max of $49.70, and a 746 ROI, with overall bullish sentiment through the period.
Market conditions, development progress, regulatory factors, and other risks could affect actual results.
Tap a question to reveal the answer.
2030 avg $4.28; min $3.04; max $6.55; ROI 46.7; sentiment BULLISH.
Long-term forecasts show bullish sentiment from 2027 through 2050, with 2050 avg $24.70 and ROI 746; 2026 is Neutral. These are estimates, not guarantees.
Yes. The 2032 max is $10.81; 2033 max $11.65; 2034 max $13.08; 2035 max $13.94; the 2050 max is $49.70.
Current price is $2.92 and market cap is $130.93M; ranking is 4099.
Sentiment is BULLISH; RSI14 is 50. SMA50 is $2.68; SMA200 is $3.77. Support sits at $2.50 and resistance at $3.19. The 30-day range is $2.34 to $3.65, and annualized volatility is 60%.
Genelux Corporation Community Discussion
0Share your Genelux Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.